Farmacoepidemiología
Indicadores de actividad 2022
- 1 proyecto público competitivo liderado (ISCIII)
- 2 proyectos privados liderados
- 1 contrato con agencia pública liderado - AEMPS
- 11 publicaciones
- FI: 62,89
- Publicaciones en Q1: 4 (36%)
- Publicaciones en D1: 2 (18%)
- 1 premio - mejor publicación en revista científica.
- Miembro de Comité Editorial: 1 IP
- Miembro de Comité Evaluador: 1 IP
Hitos destacados
-
Publications supporting the protective effect of influenza vaccine on the risk of 1) Ischemic Stroke (NEUROLOGY): Influenza Vaccination and Risk of Ischemic Stroke: A Population-Based Case-Control Study. PMID: 36240087; 2) HEART: Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study. PMID: 34645644
-
Signing of an agreement with the Fundación Renal Íñigo Álvarez de Toledo for the study of the epidemiology of chronic renal failure with the BIFAP database.
-
Participation in the "DIABECOV" project of the European REACT-EU initiative (ERDF) to carry out translational studies on diabetes and SARS-COV-2 infection.
-
Signing of a collaboration agreement with the patients' association "Osteoarthritis Foundation International" to study the comorbidity associated with osteoarthritis and the impact of the drugs used in its treatment.
-
Publication supporting the protective effect of selective serotonin reuptake inhibitors on the risk of ischemic stroke. "Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study. PMID: 35109681".
Bibliometría
Artículos | FI acum. | FI medio | Artículos Q1 ó Q2 | % en Q1 ó Q2 | Artículos D1 | % en D1 | |
---|---|---|---|---|---|---|---|
2018 | 6 | 22,08 | 3,68 | 6 | 100 | 2 | 33 |
2019 | 10 | 47,08 | 4,71 | 9 | 90 | 5 | 50 |
2020 | 9 | 87,17 | 9,69 | 9 | 67 | 1 | 11 |
2021 | 3 | 18,55 | 6,18 | 3 | 100 | 2 | 67 |
2022 | 11 | 62,89 | 5,72 | 9 | 82 | 2 | 18 |
39 | 237,77 | 5,99 | 33 | 87,70 | 12 | 35,86 |
* Sólo artículos originales, editoriales, guías y revisiones